Importantly, our study is the first to investigate the clinical impact of MPO-ANCA status in EGPA using the 2022 classification criteria, providing novel insights that differ from previous findings (derived using older criteria). Here, MPO is linked to eosinophilic granulomatosis with polyangiitis.